Aisha Hasan brings an expansive background as a scientific researcher to her global patent law practice. Aisha’s passion for creativity, particularly in the areas of immunology, molecular biology, and pharmaceuticals, inspire her to clearly define and safeguard client assets when bringing innovation to markets around the world.
Aisha focuses her practice on the preparing and prosecuting U.S. and foreign patent applications, as well all aspects of complex freedom-to-operate and due diligence reviews and IP transactions.
Aisha’s work spans a wide range of technical areas, including immunotherapies, biotechnology, small molecule pharmaceuticals, agricultural biotechnology, and diagnostic assays. Her clients include large agricultural chemical companies, pharmaceutical and biotech companies of varying size, as well as a variety of start-ups and emerging companies.
Prior to entering private practice, Aisha worked as a protein chemist at Trimeris Inc. on HIV and RSV research, as well as at the National Institutes of Health’s Laboratory of Structural Biology, where she studied the structure of natural killer cell receptors. Aisha is also skilled in clinical microbiology and virology, and chemical synthesis.
Aisha is not regularly admitted to practice law in the local courts of the District of Columbia. Pursuant to Rule 49 her practice in the District of Columbia is limited to federal courts and agencies.
Education
- North Carolina Central University School of Law, J.D., cum laude, 2006
- George Washington University, M.S., biochemistry and molecular biology, 1998
- George Mason University, B.S., biology, 1995
